Bruce Edelman, MD
Pediatric Otolaryngology · East Brunswick, NJNPI 1639276009
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Sanofi at 26.8% of the total.
Across 67 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$277
- GSK$189
- Optinose US, Inc.$130
- Novartis$79
- Takeda Pharmaceuticals U.S.A., Inc.$65
- Regeneron Healthcare Solutions, Inc.$48
- plus $246 from 12 others
What the payments were for
- Food & beverage$1,033100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 18 | $277 |
| GSK | 13 | $189 |
| Optinose US, Inc. | 9 | $130 |
| Novartis | 5 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $48 |
| Alk-abello, Inc | 3 | $41 |
| Lilly USA, LLC | 2 | $39 |
| Boston Scientific | 1 | $24 |
| Ambu Inc. | 1 | $24 |
| Acclarent, Inc | 1 | $20 |
| AstraZeneca | 1 | $17 |
| Intersect ENT, Inc. | 1 | $15 |
| Incyte Corporation | 1 | $14 |
| Kaleo, Inc. | 1 | $14 |
| CSL Behring | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
How this compares
Too few pediatric otolaryngology providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 510 | $5,878 |
| Azelastine Hcl | 76 | $2,126 |
| Ofloxacin | 78 | $1,792 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 16 | $1,705 |
| Mometasone Furoate | 111 | $1,356 |
| Levocetirizine Dihydrochloride | 60 | $1,025 |
| Famotidine | 95 | $746 |
| Ipratropium Bromide | 14 | $710 |
| Omeprazole | 67 | $647 |
| Pantoprazole Sodium | 57 | $488 |
| Fluticasone Propionate | 46 | $450 |
| Mupirocin | 69 | $436 |
| CefuroximeCefuroxime Axetil | 13 | $125 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $96 |
| Prednisone | 25 | $73 |
Paid to pharmacies, not to this prescriber.
Other pediatric otolaryngology in East Brunswick
- Kelvin KwongNew Brunswick$117K
- Ryan WalkerCherry Hill$30K
- Brian ManziLivingston$11K
- Michael TavillShrewsbury$4K
- Conor BlancoWestfield$3K
- Diana TraquinaNew Brunswick$2K
- Michael CheeHackensack$2K
- Sharyar SamadiParamus$654
- Jeffrey GinsburgRiverdale$592
- Lilun LiNew Brunswick$574
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.